ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
ESSEX INVESTMENT MANAGEMENT CO LLC 210,220$1,145,6990.19%
BRAIDWELL LP 967,690$5,273,9110.17%
Leeward Financial Partners, LLC 54,097$294,8290.16%
Rappaport Reiches Capital Management, LLC 68,080$371,0360.16%
Bouvel Investment Partners, LLC 44,199$240,8820.13%
Nebula Research & Development LLC 41,073$223,8480.12%
Edge Wealth Management LLC 90,000$490,5000.12%
PIER 88 INVESTMENT PARTNERS LLC 76,495$416,8980.10%
GILDER GAGNON HOWE & CO LLC 1,224,118$6,671,4430.10%
Point72 Asset Management, L.P. 5,713,300$31,137,4850.09%
External links

This page lists ADAPTIVE BIOTECHNOLOGIES COR's shareholders in Q3 2023. To view ADAPTIVE BIOTECHNOLOGIES COR's shareholder history, click here.